Jason Okazaki is the founder of Assembly Biosciences. Assembly Biosciences has raised $30M in total funding. Backed by Gilead Sciences, Inc..
Jason Okazaki is the chief executive officer and president of Assembly Biosciences, a biotechnology company developing innovative antiviral therapeutics. He oversees the company's efforts to advance its clinical pipeline of antiviral therapeutic candidates and has announced significant equity investments and accelerated funding to support these initiatives.
Full founder directory · Investor directory · Company funding database · Fundraising library